The Combination of PD-L1 and CTLA-4 Nano-ERASERs for TNBC Therapy
This project aims to develop a novel nanoparticle-based immunotherapy approach for treating triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of breast cancer.